Cadila falls on earnings, broker downgrades

MUMBAI Mon Feb 11, 2013 9:38am IST

A pharmacist counts pills in a pharmacy in Toronto in this January 31, 2008 file photo. REUTERS/Mark Blinch/Files

A pharmacist counts pills in a pharmacy in Toronto in this January 31, 2008 file photo.

Credit: Reuters/Mark Blinch/Files

Related Topics

Stocks

   

MUMBAI (Reuters) - Cadila Healthcare (CADI.NS) shares fell as much as 8.9 percent after October-December earnings disappointed on Friday, followed by broker downgrades.

Cadila said its December quarter net profit fell by 30.9 percent to 1.03 billion rupees.

Credit Suisse downgraded the stock to "neutral" from "outperform", citing delay in contribution from higher margin products.

(Reporting by Abhishek Vishnoi; Editing by Jijo Jacob)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

REUTERS SHOWCASE

Adani Project

Adani Project

Australia approves Adani's $16 bln Carmichael coal project  Full Article 

India-U.S. Talks

India-U.S. Talks

Kerry to woo Modi's India, but quick progress unlikely  Full Article 

Argentina Debt Default

Argentina Debt Default

Insight - Jaded Argentines brace for looming debt default   Full Article 

Anti-trust Probe

Anti-trust Probe

Microsoft targeted in apparent Chinese anti-trust probe  Full Article 

Mideast Conflict

Mideast Conflict

Israel strikes house of Hamas Gaza leader, digs in for long fight  Full Article 

Stiff Competition

Stiff Competition

China brands beat global rivals with tea toothpaste & pickled plums  Full Article 

Rising From Ashes

Rising From Ashes

With PlayStation network, Sony goes back to the future in search of revival  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage